Skip to main content
OpenTrials

Clinical trial condition

Respiratory Hypersensitivity

Explore clinical trials studying Respiratory Hypersensitivity. Study availability and eligibility vary by location and protocol.

4,447 public trials 321 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Hypersensitivity trial results

Active, Not Recruiting

TEZSPIRE (Tezepelumab) Asthma Japan Post-Marketing Study (PMS)

NCT05729711

Conditions
Asthma, Bronchial Asthma (Only the Patients With Severe or Intractable Bronchial Asthma Which Could Not be Controlled With the Existing Therapy), Bronchial Diseases, +7 more
Locations
  • Research Site Aichi, Japan
  • Research Site Akita, Japan
  • Research Site Aomori, Japan
  • Research Site Chiba, Japan
View all 33 locations
View Trial Details
Active, Not Recruiting

Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)

NCT06940141

Conditions
Asthma, Asthma Acute, Bronchial Diseases, +7 more
Locations
  • Leland Stanford Junior University, Stanford Hospital Palo Alto, California, United States
  • Amicis Research Center Valencia, California, United States
  • Nemours Children's Hospital - DE Wilmington, Delaware, United States
  • Nemours Children's Health Jacksonville, Florida, United States
View all 58 locations
View Trial Details
Active, Not Recruiting

A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma

NCT06637371

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Orange County Research Center Lake Forest, California, United States
  • Translational Clinical Research LLC Aventura, Florida, United States
  • Destiny Research Center Palmetto Bay, Florida, United States
  • ClinCept, LLC Columbus, Georgia, United States
View all 21 locations
View Trial Details
Active, Not Recruiting

Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.

NCT06473779

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +7 more
Locations
  • Research Site Palmdale, California, United States
  • Research Site Colorado Springs, Colorado, United States
  • Research Site Miami, Florida, United States
  • Research Site Boston, Massachusetts, United States
View all 70 locations
View Trial Details

Related conditions